p53 expression in human rectal tissue after radiotherapy: Upregulation in normal mucosa versus functional loss in rectal carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 3, 2002, Pages 720-728

  Marijnen, Corrie A M ^a   Kapiteijn, Ellen ^a   Nagtegaal, Iris D ^a   Mulder Stapel, Adri A ^a   Van De Velde, Cornelis J H ^a   Schrier, Peter I ^a   Peltenburg, Lucy T C ^a   Van Krieken, J Han ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ionizing radiation; p21waf1; p53; Rectal mucosa; Rectal neoplasm

Indexed keywords

IONIZING RADIATION; MUTAGENESIS; PROTEINS; TISSUE; TUMORS;

RECTAL CARCINOMAS;

RADIOTHERAPY;

BIOLOGICAL MARKER; PROTEIN P21; PROTEIN P53;

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER TISSUE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA; RECTUM MUCOSA; TUMOR CELL; WILD TYPE;

CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RECTUM; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0036498573     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02674-8     Document Type: Article

References (32)

1. Improved survival with preoperative radiotherapy in resectable rectal cancer
2. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer
3. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer: An immunohistochemical analysis
4. p53 status: An indicator for the effect of preoperative radiotherapy of rectal cancer
5. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma
6. Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: No evidence for prognostic significance
7. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer
8. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: Correlation with tumour stage and patient survival
9. p53 mutations in human cancers
10. A genetic model for colorectal tumorigenesis
11. Regulation of p53 stability by MDM2
12. MDM2 promotes the rapid degradation of p53
13. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
14. WAF1, a potential mediator of p53 tumor suppression
15. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
16. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
17. Transcriptional regulation of the p21((WAF1/CIP1)) gene
18. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter
19. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
20. Nerve growth factor-induced growth arrest and induction of p21Cip1/WAF1 in NIH-3T3 cells expressing TrkA
21. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues
22. Participation of p53 protein in the cellular response to DNA damage
23. Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: Apoptosis and cell cycle arrest
24. The ability of p53 to activate downstream genes p21(WAF1/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in SCID cells deficient in the DNA-dependent protein kinase
25. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer: Prospective randomised trial with standard operative and histopathological techniques
26. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: Histopathological study of lateral tumour spread and surgical excision
27. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas
28. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
29. The role of p53, p21WAF1/C1PI, and bcl-2 in radioresistant colorectal carcinoma
30. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells